Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Chia Tai Tianqing Pharmaceutical
Chia Tai Tianqing Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Fosaprepitant dimeglumine
Fosaprepitant dimeglumine
2021-03-03
—
Fulvestrant
Fulvestrant
2020-02-07
2034
Breast neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fulvestrant
healthy volunteers/patients
,
uterine cervical neoplasms
,
pharmacokinetics
,
pharmacological phenomena
,
lung neoplasms
,
carcinoma
,
non-small-cell lung carcinoma
,
triple negative breast neoplasms
,
ovarian neoplasms
,
endometrial neoplasms
,
prostatic neoplasms
,
systemic lupus erythematosus
,
syndrome
,
precocious puberty
,
polyostotic fibrous dysplasia
,
carcinoma in situ
,
ductal carcinoma breast
,
ductal carcinoma
,
intraductal carcinoma noninfiltrating
,
pancreatic neoplasms
,
sarcoma
,
ovarian epithelial carcinoma
,
neoplasms
,
neoplasm metastasis
,
male breast neoplasms
,
disease progression
,
progression-free survival
,
breast neoplasms
,
postmenopause
Eribulin
lymphoma
,
skin neoplasms
,
cutaneous malignant melanoma
,
abdominal neoplasms
,
retroperitoneal neoplasms
,
renal insufficiency
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
lung neoplasms
,
prostatic neoplasms
,
liposarcoma
,
inflammatory breast neoplasms
,
melanoma
,
leiomyosarcoma
,
colorectal neoplasms
,
urethral neoplasms
,
ureteral neoplasms
,
renal cell carcinoma
,
fallopian tube neoplasms
,
head and neck neoplasms
,
ewing sarcoma
,
rhabdomyosarcoma
,
pancreatic neoplasms
,
kidney neoplasms
,
pelvic neoplasms
,
colonic neoplasms
,
fatigue
,
circulating neoplastic cells
,
postmenopause
,
soft tissue neoplasms
,
malignant fibrous histiocytoma
,
residual neoplasm
,
solitary fibrous tumors
,
hemangiopericytoma
,
fibrous tissue neoplasms
,
hemangiosarcoma
,
epithelioid hemangioendothelioma
,
hemangioendothelioma
,
osteosarcoma
,
uterine cervical neoplasms
,
salivary gland neoplasms
,
castration-resistant prostatic neoplasms
,
uterine neoplasms
,
carcinosarcoma
,
mullerian mixed tumor
,
hepatocellular carcinoma
,
drug therapy
,
triple negative breast neoplasms
,
neoplasms
,
sarcoma
,
neoplasm metastasis
,
carcinoma
,
recurrence
,
non-small-cell lung carcinoma
,
brain neoplasms
,
transitional cell carcinoma
,
urinary bladder neoplasms
,
urologic neoplasms
,
hereditary breast and ovarian cancer syndrome
,
adenocarcinoma
,
brca2 genes
,
invasive hydatidiform mole
,
meningeal neoplasms
,
meningeal carcinomatosis
,
mutation
,
breast neoplasms
,
male breast neoplasms
,
drug-related side effects and adverse reactions
,
neurotoxicity syndromes
,
peripheral nervous system diseases
,
alopecia areata
,
alopecia
Eribulin mesylate
ovarian neoplasms
,
ovarian epithelial carcinoma
,
liposarcoma
,
abdominal neoplasms
,
retroperitoneal neoplasms
,
lymphoma
,
renal insufficiency
,
neoplasms
,
recurrence
,
neoplasm metastasis
,
lung neoplasms
,
ewing sarcoma
,
rhabdomyosarcoma
,
brain neoplasms
,
prostatic neoplasms
,
soft tissue neoplasms
,
residual neoplasm
,
inflammatory breast neoplasms
,
solitary fibrous tumors
,
hemangiopericytoma
,
fibrous tissue neoplasms
,
hemangiosarcoma
,
epithelioid hemangioendothelioma
,
hemangioendothelioma
,
urinary bladder neoplasms
,
uterine neoplasms
,
carcinosarcoma
,
mullerian mixed tumor
,
triple negative breast neoplasms
,
sarcoma
,
non-small-cell lung carcinoma
,
breast neoplasms
,
male breast neoplasms
,
peripheral nervous system diseases
,
alopecia areata
,
alopecia
Mycophenolate sodium
graft vs host disease
Docusate
renal cell carcinoma
,
carcinoma
,
colorectal neoplasms
,
neoplasms
,
squamous cell carcinoma of head and neck
,
melanoma
,
uterine cervical neoplasms
,
squamous cell carcinoma
,
malignant mesothelioma
,
oropharyngeal neoplasms
,
mesothelioma
,
hypersensitivity
,
drug hypersensitivity
Benzimidazole
prostatic neoplasms
Sintilimab
neoplasms
,
endometrial neoplasms
,
renal cell carcinoma
,
carcinoma
Penpulimab
colorectal neoplasms
,
stomach neoplasms
,
pancreatic neoplasms
,
esophageal squamous cell carcinoma
,
squamous cell carcinoma
,
squamous cell carcinoma of head and neck
,
large b-cell lymphoma diffuse
,
gastrointestinal neoplasms
,
thyroid neoplasms
,
breast neoplasms
,
recurrence
,
neoplasm metastasis
,
sarcoma
,
rectal neoplasms
,
pheochromocytoma
,
urologic neoplasms
,
digestive system neoplasms
,
gastrointestinal stromal tumors
,
neuroendocrine tumors
,
small cell lung carcinoma
,
female genital neoplasms
,
glioblastoma
,
uterine cervical neoplasms
,
neoplasms by histologic type
,
triple negative breast neoplasms
,
male breast neoplasms
,
essential tremor
,
head and neck neoplasms
,
syndrome
,
gastrointestinal diseases
,
digestive system diseases
,
paraganglioma
,
osteosarcoma
,
b-cell lymphoma
,
melanoma
,
esophageal neoplasms
,
adenocarcinoma
,
neoadjuvant therapy
,
immunotherapy
,
neoplasms
,
carcinoma
,
lung neoplasms
,
hepatocellular carcinoma
,
liver neoplasms
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
lymphoma
,
hodgkin disease
,
squamous cell neoplasms
,
hypersensitivity
,
non-small-cell lung carcinoma
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
small cell carcinoma
,
thyroid diseases
Lanifibranor
healthy volunteers/patients
,
pharmacokinetics
,
type 2 diabetes mellitus
,
diabetes mellitus
,
liver diseases
,
systemic scleroderma
,
diffuse scleroderma
,
sclerosis
,
non-alcoholic fatty liver disease
,
fatty liver
,
fibrosis
Gilvetmab
pancreatic neoplasms
,
stomach neoplasms
,
neuroendocrine tumors
,
intestinal neoplasms
,
renal cell carcinoma
,
prostatic neoplasms
Enoblituzumab
chronic hepatitis c
,
obesity
,
muscle diastasis
Efbemalenograstim alfa
neutropenia
,
non-small-cell lung carcinoma
,
lung neoplasms
,
febrile neutropenia
,
ovarian neoplasms
,
uterine cervical neoplasms
Aglatimagene besadenovec
prostatic neoplasms
Spartalizumab
glioblastoma
,
cutaneous malignant melanoma
,
neoplasms by histologic type
,
neoplasms by site
,
brain neoplasms
,
gliosarcoma
,
melanoma
,
neoplasms
,
squamous cell carcinoma of head and neck
,
carcinoma
,
breast neoplasms
,
pancreatic neoplasms
,
head and neck neoplasms
,
lung neoplasms
,
sarcoma
,
lymphoma
,
bile duct neoplasms
,
liver neoplasms
,
colonic neoplasms
,
squamous cell carcinoma
,
squamous cell neoplasms
,
chordoma
,
non-small-cell lung carcinoma
,
nose neoplasms
Lenograstim
neutropenia
,
leukopenia
,
neuroblastoma
,
healthy volunteers/patients
,
multiple myeloma
,
neoplasms
,
breast neoplasms
,
myeloid leukemia acute
,
myeloid leukemia
,
pain
,
lymphoma
,
paraproteinemias
,
plasmacytoma
,
plasma cell leukemia
,
plasma cell neoplasms
,
leukemia
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use